Takeda’s Julie Kim argues that Trump’s idea to match drug prices to that of other countries could cost the industry up to $1 ...

Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and ...

Takeda Pharmaceutical named Julie Kim, who heads its U.S. business, as its new chief executive starting in 2026, elevating her to the small but growing ranks of women leading Japanese companies.

When Julie Kim ’97 MBA graduated from the Kellogg School of Management ... You can sense this in other Kellogg graduates when you meet them out in the world.” President of Takeda Pharmaceutical ...

Weber – who was briefly chief operating officer of Takeda before rising to the CEO role and was the first non-Japanese person to lead the 243-year-old company – will be replaced by Julie Kim ...